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Objectives: Open surgical reconstruction for supra-aortic trunk
persists despite advances in endovascular therapy. Although extrathoracic
reconstructions (ETR) developed as a safer alternative to transthoracic
reconstructions (TTR), contemporary national data evaluating relative rates
of operative outcomes are lacking.
Methods: Using the National Surgical Quality Improvement
Program (NSQIP; 2005-2011), patients who underwent TTR or ETR
were evaluated. Patients with nonocclusive indications were excluded. The
primary outcome was a composite endpoint of cerebrovascular accident
(CVA)/myocardial infarction (MI)/death. Secondary outcomes were
30-day postoperative complications. Univariate and multivariable regression
analysis were performed.
Results: Overall, 83 (10.7%) patients underwent TTR and 692
(89.3%) underwent ETR. Vascular surgeons performed most TTR (96%)
and ETR (97%). Most common ETR were carotid-subclavian (68%),
carotid-carotid (14%), and subclavian-transposition (7%). Less commonly,
axillary-axillary (6%), subclavian-axillary (2%), subclavian-subclavian (1%),
and carotid-transposition (1%) were performed. Ten percent (TTR) and
8% (ETR) patients had a concurrent CEA at time of operation (P < .60).
Baseline characteristics are presented in table. Analysis of 20+ characteristics
showed the groups did not differ signiﬁcantly. The two groups had similar
rates of CVA (1.2% in TTR group vs 2.2% in ETR; P > .99), MI (0% vs
1.3%; P ¼ .61), death (2.4% vs 1.3%; P ¼ .33), and CVA/MI/death
(3.6% vs 3.8%; P > .99). TTR patients had longer hospital stays (6.3 days
vs 4.0; P <.0002), received more transfusions (8.4% vs 2.5%; P < .0096),
and had more septic (3.6% vs 0.3%; P < .01) and venous thromboembolic
complications (3.6% vs 0.4%; P < .02). After adjustment for other factors,
including surgical approach, CVA/MI/death was signiﬁcantly associated
with postoperative pneumonia (odds ratio, 11.0; 95% conﬁdence interval,
2.07-58.72; P < .005), and postoperative return to operating room (odds
ratio, 4.2; 95% conﬁdence interval, 1.37-12.71; P < .012).
Conclusions: At U.S. hospitals, ETR is the more common recon-
struction for supra-aortic trunk occlusive disease. Both approaches carry
acceptably low rates of death, MI, and stroke. TTR results in more resource
utilization due to its postoperative complications and greater complexity.Table. Demographic and clinical characteristics of entire cohort
Variable
Overall, %
(n ¼ 775; 100%)
Male gender 44.8%
Caucasian race 92.4%
Current smoker 45.9%
Dialysis-dependent 1.3%
History of transient ischemic attack or CVA 35.6%
History of angina or MI 5.4%
Previous percutaneous coronary intervention 17.6%
Previous cardiac surgery 18.1%
History of revascularization or amputation for
peripheral vascular disease
17.8%
History of severe chronic obstructive pulmonary
disease
15.4%
History of congestive heart failure 1.3%
Functionally independent prior to surgery 95.4%
CVA, Cerebrovascular accident; MI, myocardial infarction.
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Background: Percutaneous angioplasty 6 stenting (PTA/S) is
increasingly employed for acute (AMI) and chronic (CMI) mesenteric
ischemia. Compared with open revascularization (OR), PTA/S is associated
with increased restenosis/reintervention. It is unclear whether rising PTA/S
numbers represent treatment of new patients vs reinterventions in the same
patients.
Methods: Using the California and Florida 2006-2009 Healthcare
Cost and Utilization Project State Inpatient Databases/State Ambulatory
Surgery Databases, we identiﬁed patients with AMI and CMI undergoing
OR and PTA/S. Revisits included subsequent ambulatory PTA/S or admis-
sions with/without reintervention.
Results: There were 554 repairs for AMI (51% OR, 49% PTA/S) and
955 for CMI (17% OR, 83% PTA/S [30% ambulatory]). For AMI patients
undergoing an index OR, revisit rates at 1/2/3 years were 0.7/1.1/1.1%
for repeat OR, 0.0/0.4/0.7% for subsequent PTA/S, and 5.9/8.1/8.4%
for readmissions without repair. Revisits after PTA/S for AMI were 0.8/
1.5/1.9% for OR, 1.9/2.3/3.8% for re-PTA/S, and 8.0/10.6/11.0% for
readmission without repair. For CMI patients undergoing OR, revisit rates
were 1.4/2.8/2.8% for repeat OR, 3.5/4.9/5.6% for subsequent PTA/S,
and 4.9/4.9/5.6% for readmissions without repair. Revisits after PTA/STransthoracic, %
(n ¼ 83; 10.7%)
Extrathoracic, %
(n ¼ 692; 89.3%) P value
32.5% 46.2% .04
92.2% 92.4% .95
44.6% 46.1% .80
4.8% 0.9% .02
36.3% 35.6% .90
3.8% 5.6% .79
12.1% 18.2% .33
7.2% 19.4% .02
16.9% 17.9% .90
10.8% 15.9% .23
0% 1.5% .61
97.6% 95.1% .41
